The results of
genetic testing is very important for
ovarian cancer treatment. Gynecologic oncologist Dr. Scott Richard describes what
PARP inhibitors are, how and when they are used to treat ovarian cancer, why they are effective and how they are used for ovarian cancer types specifically linked to
genetic changes. Genetic testing can lead to more
effective treatments and
better outcomes for women with ovarian cancer.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about ovarian cancer which will help other patients, caregivers and families.
-
Share with family and friends: